LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 44 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,487,148 | +54.7% | 3,414,468 | 0.0% | 5.35% | +102.0% |
Q2 2023 | $8,720,383 | -29.9% | 3,414,468 | +24.3% | 2.65% | -19.9% |
Q1 2023 | $12,440,580 | -13.3% | 2,746,265 | -20.9% | 3.30% | -13.6% |
Q4 2022 | $14,345,001 | +31.3% | 3,473,366 | +1.7% | 3.82% | +30.1% |
Q3 2022 | $10,928,000 | +267.9% | 3,415,148 | +125.4% | 2.94% | +159.1% |
Q2 2022 | $2,970,000 | -51.6% | 1,515,148 | 0.0% | 1.13% | -56.5% |
Q1 2022 | $6,136,000 | -62.5% | 1,515,148 | 0.0% | 2.61% | -51.9% |
Q4 2021 | $16,348,000 | -6.4% | 1,515,148 | 0.0% | 5.43% | +6.4% |
Q3 2021 | $17,470,000 | +17.4% | 1,515,148 | 0.0% | 5.10% | +47.3% |
Q2 2021 | $14,879,000 | -32.8% | 1,515,148 | 0.0% | 3.46% | -21.9% |
Q1 2021 | $22,136,000 | -31.8% | 1,515,148 | 0.0% | 4.43% | -51.5% |
Q4 2020 | $32,439,000 | +41.1% | 1,515,148 | 0.0% | 9.14% | +11.8% |
Q3 2020 | $22,985,000 | +18.1% | 1,515,148 | 0.0% | 8.18% | +7.6% |
Q2 2020 | $19,470,000 | – | 1,515,148 | – | 7.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Owl Capital Holdings LP | 3,859,468 | $27,981,143 | 7.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 21,231,974 | $153,931,812 | 2.56% |
Altium Capital Management LP | 693,000 | $5,024,250 | 2.05% |
STEMPOINT CAPITAL LP | 704,349 | $5,106,530 | 1.50% |
DAFNA Capital Management LLC | 639,974 | $4,639,812 | 1.11% |
RA Capital Management | 6,045,351 | $43,828,795 | 0.58% |
Altium Capital Management LP | 196,000 | $1,421,000 | 0.58% |
MANGROVE PARTNERS IM, LLC | 855,815 | $6,204,659 | 0.48% |
Ikarian Capital, LLC | 323,528 | $2,345,578 | 0.41% |
SPHERA FUNDS MANAGEMENT LTD. | 312,469 | $2,265,400 | 0.31% |